(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SELBORNE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SELBORNE

ST13

US500000077141759

Class

5

Filing

77141759

Registration

3447685

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

30

Latest update

11/09/2018

Trademark type

Word

Nice classes

5

Filing date

03/27/2007

Registration date

06/17/2008

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/09/2018

Last transaction

11/09/2018

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Foreign priority

First use anywhere

08/31/1988

First use in commerce

1990-00-00

Drawing code

4

Owner type

99

Owner location

Longford, AU

Examiner

MUNSON OTT, MARY

Law office

L40

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Selborne Biological Services (Australia) Pty Ltd

Representatives

David J. Langeland TechLaw Ventures, PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Biological and chemical preparations and reagents for medical and veterinary usereagents for use in the development of monoclonal antibodies; culture media for medicalveterinarydiagnostic and biopharmaceutical use; biological preparations for medical purposesuse in cell cultures; blood culture media for medical and veterinary use; proteins for medical use in binding and detecting antibodies; sera for medical purposesuse in vaccinescell and tissue cultures and in growth media supplements; antisera for medical useantisera for in vivo use; antibodies for therapeutic purposesuse in therapeutic productsdiagnostic applications; bloodblood for medical purposes; blood plasmablood plasma for pharmaceutical preparationsnot as raw materials; blood grouping reagents for medical use; blood protein fractions for medical purposesuse in cell culture products and diagnostic applications; polyclonal preparationsantiseraantiplasmapolyclonal antibodieswhich are not raw materialsfor use in preparing active pharmaceutical ingredients; diagnostic preparationssubstancesagents and reagents for medicalclinical and pharmaceutical use

Publications

History of USPTO decisions and trademark events.

30 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

11/09/2018

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

11/09/2018

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

11/09/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/09/2018

E89R

TEAS SECTION 8 & 9 RECEIVED

11/01/2018

WOAG

WITHDRAWAL OF ATTORNEY GRANTED

11/22/2016

WOAR

TEAS WITHDRAWAL OF ATTORNEY RECEIVED

11/22/2016

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

02/10/2014

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

02/10/2014

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/10/2014

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

01/29/2014

E815

TEAS SECTION 8 & 15 RECEIVED

01/29/2014

R.PR

REGISTERED-PRINCIPAL REGISTER

06/17/2008

PUBO

PUBLISHED FOR OPPOSITION

04/01/2008

NPUB

NOTICE OF PUBLICATION

03/12/2008

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

02/26/2008

ALIE

ASSIGNED TO LIE

02/26/2008

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/30/2008

XAEC

EXAMINER'S AMENDMENT ENTERED

01/29/2008

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

01/29/2008

GNEA

EXAMINERS AMENDMENT E-MAILED

01/29/2008

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/29/2008

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/08/2008

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/08/2008

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/08/2008

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

07/11/2007

GNRT

NON-FINAL ACTION E-MAILED

07/11/2007

CNRT

NON-FINAL ACTION WRITTEN

07/11/2007

DOCK

ASSIGNED TO EXAMINER

07/09/2007

NWAP

NEW APPLICATION ENTERED

03/30/2007

Continuous trademark protection

Get notified about every new filing that threatens SELBORNE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.